Get the app
US › Healthcare

Elevai Labs, Inc. Common Stock (ELAB)

US · Healthcare · Biotechnology

$2.77-8.88%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$1.3M
Net profit
$-2.9M
EPS
$-0.61
Net margin
-225.1%

Key statistics

Market cap
$2.2M
Forward P/E
0.0
P/B
0.22
Book value
$27.20
EPS (TTM)
$-1,748.36
52-week high
$1,771.20
52-week low
$2.58
50-day MA
$5.18
200-day MA
$51.35
Beta
-0.27

Shareholding

Insiders
5.61%
Institutions
3.29%

Largest institutional holders

FundStake
Jane Street Group LLC1.01%
Vanguard Fiduciary Trust Co0.42%
Geode Capital Management, LLC0.30%
Vanguard Capital Management, LLC0.21%
Virtu Financial LLC0.21%
Morgan Stanley - Brokerage Accounts0.19%
XTX Topco Ltd0.17%
Tower Research Capital LLC0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Elevai Labs, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.